Cutter & Co Brokerage’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-3,333
Closed -$553K 86
2025
Q1
$553K Buy
3,333
+997
+43% +$156K 0.13% 91
2024
Q4
$338K Sell
2,336
-189
-7% -$29.3K 0.08% 126
2024
Q3
$409K Sell
2,525
-5
-0.2% -$797 0.09% 114
2024
Q2
$370K Buy
2,530
+410
+19% +$61K 0.09% 122
2024
Q1
$335K Sell
2,120
-776
-27% -$124K 0.08% 129
2023
Q4
$454K Sell
2,896
-764
-21% -$117K 0.13% 98
2023
Q3
$570K Sell
3,660
-248
-6% -$40.9K 0.17% 84
2023
Q2
$647K Buy
3,908
+558
+17% +$90.1K 0.19% 77
2023
Q1
$519K Sell
3,350
-537
-14% -$86.7K 0.16% 96
2022
Q4
$687K Sell
3,887
-127
-3% -$21.9K 0.23% 77
2022
Q3
$656K Sell
4,014
-151
-4% -$25.6K 0.24% 77
2022
Q2
$739K Buy
4,165
+83
+2% +$14.8K 0.25% 85
2022
Q1
$723K Sell
4,082
-587
-13% -$99.9K 0.22% 90
2021
Q4
$799K Buy
4,669
+461
+11% +$75.5K 0.22% 95
2021
Q3
$680K Sell
4,208
-142
-3% -$24.2K 0.16% 130
2021
Q2
$717K Sell
4,350
-5
-0.1% -$828 0.16% 123
2021
Q1
$716K Sell
4,355
-767
-15% -$124K 0.17% 119
2020
Q4
$806K Buy
5,122
+253
+5% +$37.3K 0.21% 102
2020
Q3
$725K Buy
4,869
+653
+15% +$96.6K 0.21% 98
2020
Q2
$593K Sell
4,216
-1,148
-21% -$167K 0.19% 109
2020
Q1
$385K Sell
5,364
-9,410
-64% -$1.34M 0.15% 126
2019
Q4
$2.15M Sell
14,774
-7,510
-34% -$1.02M 0.76% 38
2019
Q3
$2.88M Sell
22,284
-1,465
-6% -$193K 0.93% 23
2019
Q2
$3.31M Buy
23,749
+674
+3% +$93.3K 1.04% 21
2019
Q1
$3.23M Sell
23,075
-385
-2% -$51.6K 0.92% 22
2018
Q4
$3.03M Buy
23,460
+1,423
+6% +$198K 1.15% 16
2018
Q3
$3.04M Buy
22,037
+1,839
+9% +$244K 1.04% 23
2018
Q2
$2.45M Sell
20,198
-4
-0% -$499 0.95% 25
2018
Q1
$2.59M Buy
20,202
+1,064
+6% +$144K 1.02% 23
2017
Q4
$2.67M Sell
19,138
-1,329
-6% -$185K 1.1% 21
2017
Q3
$2.66M Sell
20,467
-243
-1% -$32.2K 1.05% 23
2017
Q2
$2.74M Sell
20,710
-153
-0.7% -$19.5K 1.08% 21
2017
Q1
$2.6M Sell
20,863
-5,044
-19% -$603K 1.07% 24
2016
Q4
$2.98M Sell
25,907
-479
-2% -$55.3K 1.24% 18
2016
Q3
$3.12M Buy
26,386
+2,598
+11% +$315K 1.36% 17
2016
Q2
$2.89M Sell
23,788
-249
-1% -$28.3K 1.23% 19
2016
Q1
$2.6M Buy
24,037
+2,643
+12% +$274K 1.2% 19
2015
Q4
$2.2M Buy
21,394
+273
+1% +$27.5K 1.03% 27
2015
Q3
$1.97M Sell
21,121
-2,140
-9% -$207K 0.97% 29
2015
Q2
$2.27M Buy
23,261
+1,472
+7% +$147K 0.9% 35
2015
Q1
$2.19M Sell
21,789
-618
-3% -$62.8K 0.89% 37
2014
Q4
$2.34M Buy
22,407
+182
+0.8% +$19.2K 0.89% 37
2014
Q3
$2.37M Buy
22,225
+263
+1% +$27.3K 0.91% 38
2014
Q2
$2.3M Sell
21,962
-2,370
-10% -$240K 0.84% 45
2014
Q1
$2.39M Buy
24,332
+3,513
+17% +$326K 0.94% 42
2013
Q4
$1.91M Sell
20,819
-1,836
-8% -$169K 0.89% 41
2013
Q3
$1.96M Buy
22,655
+118
+0.5% +$10.6K 0.88% 42
2013
Q2
$1.94M Buy
+22,537
New +$1.91M 0.92% 37

Other funds holding JNJ

Cutter & Co Brokerage's JNJ Position: Q2 2025 in Review

Cutter & Co Brokerage sold out of Johnson & Johnson (JNJ) in Q2 2025, closing a stake of 3,333 shares — an estimated $553K sold.

Cutter & Co Brokerage first reported a position in JNJ in Q2 2013 and held it in 48 quarters. The position peaked at $3.31M in Q2 2019. 4,083 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Cutter & Co Brokerage reported no remaining Johnson & Johnson position as of Q2 2025 after selling out during the quarter.
  • Cutter & Co Brokerage sold 3,333 Johnson & Johnson shares in Q2 2025, an estimated $553K.
  • Cutter & Co Brokerage first reported a position in Johnson & Johnson in Q2 2013 and held it in 48 quarters.
  • Cutter & Co Brokerage's Johnson & Johnson position peaked at $3.31M in Q2 2019.
  • 4,083 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Cutter & Co Brokerage's 13F filing for Q2 2025.